U.S. Physical Therapy, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Christopher J. Reading
- Full Time Employees
- 6,374
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 1300 West Sam Houston Parkway South Houston TX United States of America 77042
- IPO Date
- May 29, 1992
- CIK
- 0000885978
- Website
- usph.com
- Similar Companies
- Business
- U.S. Physical Therapy, Inc. U.S. Physical Therapy, Inc. (NYSE: USPH) operates as one of the largest publicly traded providers of outpatient physical and occupational therapy clinics across the United States, delivering pre- and post-operative care for orthopedic-related disorders and sports-related injuries; treatment for neurologically-impaired patients; rehabilitation services for injured workers; and management of physical therapy facilities for third parties such as hospitals and physician groups. Founded in 1990 and headquartered in Houston, Texas, the company also maintains an industrial injury prevention segment through its subsidiary, offering onsite services including injury prevention programs, rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments to corporate clients nationwide. Its clinics, numbering in the hundreds across more than 40 states, primarily serve patients covered by managed care plans, commercial health insurance, Medicare/Medicaid, workers' compensation, and personal injury proceeds. In recent developments, U.S. Physical Therapy, Inc. acquired a 50% equity interest in Metro Physical & Aquatic Therapy's management services organization for approximately $76.5 million plus a potential $20 million earnout in late 2024, marking its entry into the New York market with a high-growth operator generating $64 million in annual revenue; completed the purchase of a 50-clinic physical therapy practice and multiple smaller acquisitions such as nine-clinic, eight-clinic, and three-clinic practices in 2024 and 2025; and reported industrial injury prevention revenue growth of 14.6% in the third quarter of 2025, alongside ongoing expansions through satellite clinic developments and partnerships.
U.S. Physical Therapy Announces CFO
U.S. Physical Therapy Q2 Earnings Call Highlights
U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript
U.S. Physical Therapy Continues To Heal
U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates
U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance
U.S. Physical Therapy, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call Dates
U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare Conference
U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Transcript
U.S. Physical Therapy (USPH) Q1 Earnings and Revenues Lag Estimates
Here's What Key Metrics Tell Us About U.S. Physical Therapy (USPH) Q1 Earnings
U.S. Physical Therapy Reports Record First Quarter Revenue, Reaffirms Full Year Guidance
U.S. Physical Therapy, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call Dates
U.S. Physical Therapy Announces $450 Million Credit Facility
JPMorgan Chase & Co. Purchases 56,752 Shares of U.S. Physical Therapy, Inc. $USPH
Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $104.50
U.S. Physical Therapy Presented at the Barclays 28th Annual Global Healthcare Conference